-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
- Sarepta Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $7.12M, a 23.9% decline year-over-year.
- Sarepta Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $14.9M, a 34.1% decline year-over-year.
- Sarepta Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $15.9M, a 17.4% increase from 2022.
- Sarepta Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $13.5M.
- Sarepta Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$168K, a 116% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)